News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zafgen (ZFGN) Announces Pricing of Initial Public Offering


6/19/2014 8:22:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass., June 18, 2014 (GLOBE NEWSWIRE) -- Zafgen, Inc., a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at a price to the public of $16.00 per share, before underwriting discounts. All of the common stock is being offered by Zafgen. In addition, Zafgen has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock to cover over-allotments, if any. The shares are expected to begin trading on the NASDAQ Global Market on June 19, 2014 under the symbol "ZFGN."

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Zafgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES